Difference between revisions of "Case Studies/Tuberculosis Commons"

From Creative Commons
Jump to: navigation, search
(Created page with "{{Case Study |Description=The current model of drug development is slow and inefficient. In a 2005 JAMA commentary, Andrew S. Grove, PhD, former Chairman of Intel, posits that th...")
 
(No difference)

Latest revision as of 19:34, 29 October 2011


License Used
unspecified
Media
Image, Sound, Text, MovingImage, InteractiveResource, Data
2011
Tags
Tuberculosis Commons, tuberculosis, CC0
Translations

.


Evaluation Information.png
Page Importance:
Page Quality:
The current model of drug development is slow and inefficient. In a 2005 JAMA commentary, Andrew S. Grove, PhD, former Chairman of Intel, posits that the dominant cause is the slow rate of knowledge turns in the healthcare industry. "Knowledge turns are indicators of the time it takes for an experiment to proceed from hypothesis to results and then lead to a new hypothesis and a new result."

We agree.

The Clinical Open Innovation Team believes that open models can accelerate knowledge turns resulting in a faster drug development process. We are responding to this challenge, starting with the TB Commons initiative.

This initiative seeks to build a commons. The word “commons” in the digital space means what it does in physical space: It is a shared, public place for collecting and sharing resources for a community. This can include open data, shared expertise, software, and discourse.

The goal of the TB Commons initiative is to seed and grow an open clinical intelligence network. Our mental model for this focuses on four core community activities:

Collect. Gather and convert available public clinical data to standard web-enabled formats Consume. Personalize views of data for exploration and understanding Curate. Generate new insights by linking, annotating, and organizing data in new ways Connect. Inspire community members to create networks of people and knowledge

TB Commons is an open innovation in progress. You can become part of the process of reinventing invention. Build a collection, explore what you've built, and engage with others.

Content provided by end-users to the site that is unique and not subject to preexisting licensing shall be provided and licensed under Creative Commons Public Domain, or CC0. This means that the Content has been dedicated to the public domain and that the end-user has waived all copyright and other rights in the Content worldwide. Further, there are no restrictions or requirements on the use of the Content.


Overview

Please provide an overview of the work. Describe the author or organization (location, funding/business model, partner organizations), objectives, current projects.

Delete the above questions and add text here.

License Usage

Please specify the license adopted. How is the license applied? Can you provide any available statistics? What has been the author or organization's experience with Creative Commons licenses so far – what have been the benefits and lessons learned?

Delete the above questions and add text here.

Motivations

How did the author or organization first hear about Creative Commons? Why did they choose to license under Creative Commons? Which license did they select and why? Any other issues you may have come across/comments you’d like to make.

Delete the above questions and add text here.

Impact

What is the impact of this CC-enabled project or resource? Specifically, what has the license enabled that otherwise would not exist? Provide statistics or other data if possible.

Delete the above questions and add text here.

Technical Details

Provide any technical details of the implementation here

Media

Please include any screenshots, logos, links to videos, audio files, press hits, etc. To upload a file, open a separate window and click through Special:Upload.

Delete the above questions and add text here.